Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

NeuroRPM

Tracked across 1 events · 7 articles · First seen Mar 19, 2026 · Last active Mar 19, 2026

Sentiment
40
Attention
2
Events
1
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
2 40
Business
NeuroRPM is partnering with Annovis Bio to deploy its FDA-cleared AI platform for monitoring Parkinson's disease symptoms in a clinical trial. This partnership provides a significant opportunity for NeuroRPM to expand the use of its technology in clinical research and potentially in patient care.
Mar 19, 2026 · 7 articles
Annovis Bio partner NeuroRPM Annovis Bio and NeuroRPM are partners in a clinical study for Parkinson's diseas
Collaborative Fusion CEO NeuroRPM Collaborative Fusion is the CEO of NeuroRPM.
NEWSDESK
Track NeuroRPM live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.